Trimethyl orthoformate → HCID 25214475, compound
Reaction equation
[CH2:1]1[C:10]2[C:5](=[C:6]([O:11][C:12]3[C:17]([NH:18][C:19]([NH:21][C:22]4[CH:27]=[CH:26][C:25]([O:28][C:29]([F:32])([F:31])[F:30])=[CH:24][CH:23]=4)=[O:20])=[CH:16][CH:15]=[CH:14][N:13]=3)[CH:7]=[CH:8][CH:9]=2)[CH2:4][CH2:3][NH:2]1.[CH:33]1([CH:39]=O)[CH2:38][CH2:37][CH2:36][CH2:35][CH2:34]1.COC(OC)OC.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C>CO.C(O)(=O)C.CN1C(=O)CCC1>[CH:33]1([CH2:39][N:2]2[CH2:3][CH2:4][C:5]3[C:10](=[CH:9][CH:8]=[CH:7][C:6]=3[O:11][C:12]3[C:17]([NH:18][C:19]([NH:21][C:22]4[CH:27]=[CH:26][C:25]([O:28][C:29]([F:32])([F:30])[F:31])=[CH:24][CH:23]=4)=[O:20])=[CH:16][CH:15]=[CH:14][N:13]=3)[CH2:1]2)[CH2:38][CH2:37][CH2:36][CH2:35][CH2:34]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
A mixture of 1-(2-(1,2,3,4-tetrahydroisoquinolin-5-yloxy)pyridin-3-yl)-3-(4-(trifluoromethoxy)phenyl)urea (238f, 15 mg, 0.034 mmol), cyclohexanecarboxaldehyde (38 mg, 034 mmol), acetic acid (50 μL) were added to NMP (0.75 mL) and trimethylorthoformate (0.5 mL) and stirred at rt for 2.5 h. Triacetoxyborohydride (36 mg) was added and stirring was continued for 18 h. A solution of acetic acid in methanol (50% v/v, 0.5 mL) was added and reaction mixture was directly purified on preparative HPLC to yield the desired material (5.4 mg). (M+H)+=541. 1H NMR (400 MHz, DMSO-D6) δ ppm 1.6-1.9 (m, 10H), 2.32 (m, 1H), 3.04-3.06 (m, 2H), 3.66-3.75 (m, 2H), 4.31-4.43 (m, 2H), 4.60-4.70 (m, 2H), 7.11 (dd, J=7.83, 4.80 Hz, 1H), 7.18 (t, J=7.83 Hz, 2H), 7.33 (d, J=8.08 Hz, 2H), 7.39 (t, J=7.83 Hz, 1H), 7.56 (d, J=9.09 Hz, 2H), 7.65 (dd, J=4.80, 1.76 Hz, 1H), 8.53 (d, J=7.84 Hz, 1H), 8.78 (s, 1H), 9.54 (s, 1H).
Workup
- stirringstirring
- waitwas continued for 18 h
- customreaction mixture
- customwas directly purified on preparative HPLC
Sources & evidence
- ORD record
- ord-b6915a56dc3a414087c27b4e6fac8c9c
- Source dataset
- uspto-grants-2010_03
- Patent number
- US07674828B2
Reaction notes
Loading…